Nothing Special   »   [go: up one dir, main page]

BR0010558A - Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico - Google Patents

Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico

Info

Publication number
BR0010558A
BR0010558A BR0010558-9A BR0010558A BR0010558A BR 0010558 A BR0010558 A BR 0010558A BR 0010558 A BR0010558 A BR 0010558A BR 0010558 A BR0010558 A BR 0010558A
Authority
BR
Brazil
Prior art keywords
methods
gastric cancer
predict
cancer risk
risk
Prior art date
Application number
BR0010558-9A
Other languages
English (en)
Inventor
Robert Llewellyn Clancy
Gerald Pang
Original Assignee
Onco Alert Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onco Alert Pty Ltd filed Critical Onco Alert Pty Ltd
Publication of BR0010558A publication Critical patent/BR0010558A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5406—IL-4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: "MéTODOS PARA PROGNOSTICAR E/OU DIAGNOSTICAR O RISCO DE CâNCER GáSTRICO". A presente invenção refere-se a métodos de prognosticar o risco de desenvolver câncer e em particular a um método para diagnosticar e/ou prognosticar o risco de desenvolver câncer gástrico em um indivíduo infectado com Heliobacter.
BR0010558-9A 1999-05-14 2000-05-15 Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico BR0010558A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ0377A AUPQ037799A0 (en) 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer
PCT/AU2000/000441 WO2000070348A1 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer

Publications (1)

Publication Number Publication Date
BR0010558A true BR0010558A (pt) 2002-02-19

Family

ID=3814581

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010558-9A BR0010558A (pt) 1999-05-14 2000-05-15 Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico

Country Status (10)

Country Link
EP (1) EP1183540A4 (pt)
JP (1) JP2002544520A (pt)
KR (1) KR20020033093A (pt)
CN (1) CN1355885A (pt)
AU (1) AUPQ037799A0 (pt)
BR (1) BR0010558A (pt)
CA (1) CA2372761A1 (pt)
HK (1) HK1044988A1 (pt)
MX (1) MXPA01011721A (pt)
WO (1) WO2000070348A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
GB2430031A (en) * 2005-09-07 2007-03-14 Ethicon Inc Diagnostic markers of wound infection
KR20140074293A (ko) * 2011-09-14 2014-06-17 바스프 에스이 신장 독성을 평가하기 위한 수단 및 방법
JP6707248B2 (ja) * 2013-12-05 2020-06-10 学校法人北里研究所 胃癌細胞の検出方法、及び胃癌細胞検出キット
RU2706118C1 (ru) * 2019-04-30 2019-11-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Способ прогнозирования предраковых заболеваний желудка
CN117143234B (zh) * 2023-08-29 2024-05-03 武汉爱博泰克生物科技有限公司 抗大鼠白细胞介素-4蛋白的单克隆抗体及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012965A1 (en) * 1994-10-20 1996-05-02 Genelabs Diagnostics Pte Ltd. Helicobacter pylori diagnostic methods and kits
IT1289578B1 (it) * 1996-12-06 1998-10-15 Sanitaria Scaligera Spa Immunopurificazione di un antigene dall'apparente peso molecolare di 16 +- 2 kda dell' helicobacter pylori e metodi per la sua

Also Published As

Publication number Publication date
CA2372761A1 (en) 2000-11-23
KR20020033093A (ko) 2002-05-04
AUPQ037799A0 (en) 1999-06-10
WO2000070348A1 (en) 2000-11-23
EP1183540A1 (en) 2002-03-06
HK1044988A1 (zh) 2002-11-08
JP2002544520A (ja) 2002-12-24
MXPA01011721A (es) 2003-09-10
EP1183540A4 (en) 2007-07-04
CN1355885A (zh) 2002-06-26

Similar Documents

Publication Publication Date Title
BRPI0503443A (pt) verificação de caso teste automatizada que é acoplada de forma livre em relação à execução de caso teste automatizado
CY1112261T1 (el) Μεσο για τον προσδιορισμο του προφιλ κινδυνου ενος ατομου για την αθηροσκληρωτικη νοσο
AU2003230838A8 (en) Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets
EP1466179A4 (en) METHOD FOR DIAGNOSIS OF CANCER DISORDERS BY MEASURING THE CHANGES TO GLOBALIZATION OF PROTEINS RELATED TO TUMOR FORMATION AND METASTASE, AND TO THE USE THEREOF FOR THE DIAGNOSIS OF CANCER DISORDERS
WO2000035436A3 (en) Treatment of arthritis with mek inhibitors
TR200102499T2 (tr) Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi
ATE424560T1 (de) Marker für neuromyelitis optica
HK1030018A1 (en) Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
BR0112644A (pt) Método de identificar marcadores de câncer e usos destes no diagnóstico do câncer
DE60228557D1 (de) Candida-nachweis
BR0115715A (pt) Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
DK1075277T4 (da) Fremgangsmåder til detektion og inhibering af angiogenese
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
DE60322848D1 (de) System für kontinuierliche leistungstests
BR0010558A (pt) Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico
BRPI0512948A (pt) biomarcadores de mal de alzheimer
NO20052553D0 (no) Cobalaminanalyse.
BRPI0414365A (pt) composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes
ATE489624T1 (de) Antikörper gegen histonmodifikationen für die klinische krebsdiagnose und -prognose
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
BR0115689A (pt) Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
NO20002176D0 (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom
ATE515576T1 (de) Protein c polymorphismen
BR0308117A (pt) Dìmeros de avidina eficazes em aumentar a concentração de biotina radioativa em radioimunoterapia pré-direcionada
BRPI0415562A (pt) reagente para avaliação diagnóstica e/ou prognóstica de carcinoma, métodos para determinação de p-lap que é um fator prognóstico em carcinoma, e para avaliação prognóstica de carcinoma, e, kit de imunoensaio para determinação da quantidade de p-lap presente em tecidos de carcinoma

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADDE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010.